Verastem will present late-breaking data from the RAMP 201 and RAMP 201J trials of avutometinib plus defactinib at the IGCSociety2026 annual meeting. The announcement included no study results or clinical details.
published
Verastem will present late-breaking data from the RAMP 201 and RAMP 201J trials of avutometinib plus defactinib at the IGCSociety2026 annual meeting. The announcement included no study results or clinical details.
Latest documented BWB result
See Billy's timestamped results and follow-through.
Review the latest gains posts, original timestamps, and proof images published by Banking With Billy.
Historical results are not a promise of future performance. Trading involves substantial risk.This public post is a timestamped information archive, not personalized financial advice. Alerts can change as markets move. Join Billy's private group for the complete daily stream and follow-through.